Home › NDC Lookup › RxCUI directory › RxCUI 2272124

Avapritinib 300 MG Oral Tablet — RxCUI 2272124

RxNorm drug concept · Semantic clinical drug
RxCUI 2272124 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2272124
Official nameAvapritinib 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)73 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Avapritinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ayvakit is not traditional chemotherapy. It's what's called a targeted therapy — a drug designed to zero in on specific mutant proteins (KIT and PDGFRA) that are driving your tumor...
  • What exactly is Ayvakit treating — is it chemotherapy?
  • Yes, timing really matters here. You need to take Ayvakit on an empty stomach — at least 1 hour before eating or 2 hours after your last meal. A high-fat meal can raise the amount...
  • Does it matter when I take it — can I take it with breakfast?
📖 Read our full Avapritinib guide →

🕸️ Concept Web — How Avapritinib 300 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Avapritinib 300 MG Oral Tablet RxCUI 2272124

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Avapritinib 2272107
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ayvakit 2272113
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Avapritinib Oral Tablet 2272111
    • Avapritinib Oral Product 2272109
    • Avapritinib Pill 2272110
    • Avapritinib Oral Tablet [Ayvakit] 2272115
    • Ayvakit Oral Product 2272116
    • Ayvakit Pill 2272117
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Avapritinib 300 MG SCDC · 2272123
  • Avapritinib Oral Tablet SCDF · 2272111
  • Avapritinib Oral Product SCDG · 2272109
  • Avapritinib Pill SCDG · 2272110

Brand-Name Concepts

  • Avapritinib 300 MG Oral Tablet [Ayvakit] SBD · 2272126
  • Avapritinib 300 MG [Ayvakit] SBDC · 2272125
  • Avapritinib Oral Tablet [Ayvakit] SBDF · 2272115
  • Ayvakit Oral Product SBDG · 2272116
  • Ayvakit Pill SBDG · 2272117
  • Ayvakit BN · 2272113

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 2272124 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72064-0110-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72064-110-30) Ayvakit Blueprint Medicines Corporation 2020-01-09
72064-0120-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72064-120-30) Ayvakit Blueprint Medicines Corporation 2020-01-09
72064-0125-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72064-125-30) Ayvakit Blueprint Medicines Corporation 2021-06-16
72064-0130-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72064-130-30) Ayvakit Blueprint Medicines Corporation 2020-01-09
72064-0150-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72064-150-30) Ayvakit Blueprint Medicines Corporation 2021-06-16
Observed labelers: Blueprint Medicines Corporation (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.